Overview

Exploratory Study of OPC-12759 Ophthalmic Suspension

Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of OPC-12759 ophthalmic suspension for patients with keratoconjunctival epithelial disorder compared with sodium hyaluronate. Also, safety of OPC-12759 is to be assessed.
Phase:
Phase 2
Details
Lead Sponsor:
Otsuka Pharmaceutical Co., Ltd.
Treatments:
Hyaluronic Acid
Ophthalmic Solutions
Pharmaceutical Solutions
Rebamipide